Vaxine Pty Ltd
Clinical trials sponsored by Vaxine Pty Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New vaccine aims to control or cure chronic hepatitis b Results expected Mar 2027 (estimated)
-
New COVID-19 vaccine shows promise in small trial
Vaccine CompletedThis study tested a new COVID-19 vaccine called SpikoGen in 39 adults who had never received a COVID-19 vaccine. Participants received two doses one month apart, followed by a third booster dose either one or three months later. The goal was to see how well the vaccine triggered …
Phase 3 • Sponsor: Vaxine Pty Ltd • Aim: Vaccine
Last updated Jun 26, 2026 17:42 UTC
-
SpikoGen booster shows promise in small COVID-19 study
Disease control CompletedThis study tested the SpikoGen vaccine as a booster shot in 81 adults who had already received a full course of any COVID-19 vaccine. The goal was to see if a third or fourth dose of SpikoGen could raise antibody levels and provide protection. Researchers measured immune response…
Phase 3 • Sponsor: Vaxine Pty Ltd • Aim: Disease control
Last updated Jun 26, 2026 18:22 UTC